FDA Drug Recalls

Recalls / Class II

Class IID-1279-2014

Product

Fluoxetine Capsules, USP, 20 mg, 30-count bottles, Rx only, Distributed by: Wal-Mart, Bentonville, AR 72716; Manufactured by: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960; Packaged by: Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045, NDC 68645-130-54, UPC 3 68645 13054 5.

Brand name
Fluoxetine
Generic name
Fluoxetine
Active ingredient
Fluoxetine Hydrochloride
Route
Oral
NDCs
68645-130, 68645-131
FDA application
ANDA076001
Affected lot / code info
Lot numbers: 131328, Exp 08/15; 131634, Exp 09/15; and 131833, Exp 11/15

Why it was recalled

Chemical Contamination: The recalling firm received notice that their supplier is recalling capsules due to complaints of capsules having an unusual odor.

Recalling firm

Firm
Legacy Pharmaceutical Packaging
Manufacturer
Legacy Pharmaceutical Packaging, LLC
Notification channel
Telephone
Type
Voluntary: Firm initiated
Address
13333 Lakefront Dr, Earth City, Missouri 63045-1514

Distribution

Quantity
667,068 bottles
Distribution pattern
Nationwide

Timeline

Recall initiated
2014-02-14
FDA classified
2014-04-28
Posted by FDA
2014-05-07
Terminated
2017-11-27
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1279-2014. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.